[PDF][PDF] Platelet factor 4 mediates inflammation in experimental cerebral malaria

K Srivastava, IA Cockburn, AM Swaim, LE Thompson… - Cell host & …, 2008 - cell.com
K Srivastava, IA Cockburn, AM Swaim, LE Thompson, A Tripathi, CA Fletcher, EM Shirk…
Cell host & microbe, 2008cell.com
Cerebral malaria (CM) is a major complication of Plasmodium falciparum infection in
children. The pathogenesis of CM involves vascular inflammation, immune stimulation, and
obstruction of cerebral capillaries. Platelets have a prominent role in both immune
responses and vascular obstruction. We now demonstrate that the platelet-derived
chemokine, platelet factor 4 (PF4)/CXCL4, promotes the development of experimental
cerebral malaria (ECM). Plasmodium-infected red blood cells (RBCs) activated platelets …
Summary
Cerebral malaria (CM) is a major complication of Plasmodium falciparum infection in children. The pathogenesis of CM involves vascular inflammation, immune stimulation, and obstruction of cerebral capillaries. Platelets have a prominent role in both immune responses and vascular obstruction. We now demonstrate that the platelet-derived chemokine, platelet factor 4 (PF4)/CXCL4, promotes the development of experimental cerebral malaria (ECM). Plasmodium-infected red blood cells (RBCs) activated platelets independently of vascular effects, resulting in increased plasma PF4. PF4 or chemokine receptor CXCR3 null mice had less severe ECM, including decreased T cell recruitment to the brain, and platelet depletion or aspirin treatment reduced the development of ECM. We conclude that Plasmodium-infected RBCs can directly activate platelets, and platelet-derived PF4 then contributes to immune activation and T cell trafficking as part of the pathogenesis of ECM.
cell.com